Showing results (1-10 of 275) with videos related to
Sort By:
Pageof 28
Expert Review of Clinical Pharmacology|July 5, 2018
Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotypeKhalid Al Efraij, J Mark FitzGeraldExpert Opinion on Emerging Drugs|August 24, 2017
Emerging interleukin receptor antagonists for the treatment of asthmaKhalid Al Efraij, J Mark FitzGeraldJournal of Thoracic Disease|December 31, 2015
Current and emerging treatments for severe asthmaKhalid Al Efraij, J Mark FitzGeraldThe Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 5, 2018
A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthmaKhalid Al Efraij, Kate M Johnson, Darrin Wiebe, et al.Respiratory Medicine|September 27, 2017
The impact of inappropriate use of short acting beta agonists in asthmaJ Mark FitzGerald, Hamid Tavakoli, Larry D Lynd, et al.Cancer Medicine|March 3, 2015
Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumorsKhalid Al-Efraij, Mohammed A Aljama, Hagen Fritz KenneckeBMJ Case Reports|December 4, 2012
Pleomorphic rhabdomyosarcoma with pulmonary tumour embolismSalman Abdulaziz, Mohammed Geddawy, Khalid Al Efraij, et al.The Journal of Allergy and Clinical Immunology|February 18, 2010
Achieving asthma control in patients with moderate diseaseJ Mark FitzGerald, Neal ShahidiJournal of Asthma and Allergy|March 26, 2011
Current recommendations for the treatment of mild asthmaNeal Shahidi, J Mark FitzgeraldThe Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|June 3, 2008
Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluationElizabeth Miller, J Mark FitzGeraldPageof 28